BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20100679)

  • 1. Current and future applications of toxicogenomics: Results summary of a survey from the HESI Genomics State of Science Subcommittee.
    Pettit S; des Etages SA; Mylecraine L; Snyder R; Fostel J; Dunn RT; Haymes K; Duval M; Stevens J; Afshari C; Vickers A
    Environ Health Perspect; 2010 Jul; 118(7):992-7. PubMed ID: 20100679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicogenomics: A 2020 Vision.
    Liu Z; Huang R; Roberts R; Tong W
    Trends Pharmacol Sci; 2019 Feb; 40(2):92-103. PubMed ID: 30594306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicogenomics: the challenges and opportunities to identify biomarkers, signatures and thresholds to support mode-of-action.
    Currie RA
    Mutat Res; 2012 Aug; 746(2):97-103. PubMed ID: 22445948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicogenomics and its application in safety evaluation of traditional Chinese medicine].
    Lian XP; Ai N; Lu XY; Fan XH
    Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(14):2690-5. PubMed ID: 26666010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V; Le Fevre AC; Boitier E
    Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicogenomics in risk assessment: an overview of an HESI collaborative research program.
    Pennie W; Pettit SD; Lord PG
    Environ Health Perspect; 2004 Mar; 112(4):417-9. PubMed ID: 15033589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.
    Luebke RW; Holsapple MP; Ladics GS; Luster MI; Selgrade M; Smialowicz RJ; Woolhiser MR; Germolec DR
    Toxicol Sci; 2006 Nov; 94(1):22-7. PubMed ID: 16882865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomic biomarkers for liver toxicity.
    Kiyosawa N; Ando Y; Manabe S; Yamoto T
    J Toxicol Pathol; 2009 Mar; 22(1):35-52. PubMed ID: 22271975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a practical toxicogenomics data analysis system utilizing open-source software.
    Hirai T; Kiyosawa N
    Methods Mol Biol; 2013; 930():357-74. PubMed ID: 23086850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Database development in toxicogenomics: issues and efforts.
    Mattes WB; Pettit SD; Sansone SA; Bushel PR; Waters MD
    Environ Health Perspect; 2004 Mar; 112(4):495-505. PubMed ID: 15033600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicogenomics in drug discovery and development -- making an impact.
    Wills Q; Mitchell C
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():33-7. PubMed ID: 19807202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics: regulatory perspective on current position.
    Battershill JM
    Hum Exp Toxicol; 2005 Jan; 24(1):35-40. PubMed ID: 15727054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment.
    Serra A; Fratello M; Cattelani L; Liampa I; Melagraki G; Kohonen P; Nymark P; Federico A; Kinaret PAS; Jagiello K; Ha MK; Choi JS; Sanabria N; Gulumian M; Puzyn T; Yoon TH; Sarimveis H; Grafström R; Afantitis A; Greco D
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32276469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
    Youns M; Hoheisel JD; Efferth T
    Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovering functional modules by topic modeling RNA-Seq based toxicogenomic data.
    Yu K; Gong B; Lee M; Liu Z; Xu J; Perkins R; Tong W
    Chem Res Toxicol; 2014 Sep; 27(9):1528-36. PubMed ID: 25083553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.